Billy Michael Chelliah Jebaraj

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Qu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, Alicja Pacholewska, Christoph Markus Aszyk, Francien Grotenhuijs, Tony Andreas Müller, Özlem Önder, Prerana Wagle, Carmen Diana Herling, Maria Kleppe, Zhefang Wang, Kevin R Coombes, Sandra Robrecht, Priya S Dalvi, Bianca Andra Lungu, Petra Mayer, Lynne V Abruzzo, Janine Altmüller, Birgit Sybille Gathof, Thorsten Persigehl, Kirsten Fischer, Billy Michael Chelliah Jebaraj, Hugh Young Rienhoff, Rupert C Ecker, Yue Zhao, Christiane Josephine Bruns, Stephan Stilgenbauer, Kojo S J Elenitoba-Johnson, Michael Hallek, Michal R Schweiger, Margarete Odenthal, Elena Vasyutina, Marco Herling
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia. Blood (2023)
Jialei Qi, Sascha Endres, Deyan Yordanov Yosifov, Eugen Tausch, Rashmi Priyadharshini Dheenadayalan, Xiang Gao, Annika Müller, Christof Schneider, Daniel Mertens, Peter Gierschik, Martin Wist, Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer
Acquired BTK mutations associated with resistance to non-covalent BTK inhibitors. Blood advances (2023)

Billy Michael Chelliah Jebaraj.css-eqlu8i{font-size:small;padding-left:4px;}